CyberKnife Radiosurgery for Organ-Confined Prostate Cancer: Homogenous Dose Distribution

NACompletedINTERVENTIONAL
Enrollment

379

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

January 27, 2021

Study Completion Date

January 27, 2021

Conditions
Prostate CancerProstatic CancerProstate NeoplasmsProstatic NeoplasmsCancer of the Prostate
Interventions
RADIATION

CyberKnife Stereotactic Radiosurgery

36.25 Gy delivered in 5 fractions of 7.25 Gy per fraction

Trial Locations (23)

15057

Hematology Oncology Associates of Central New York, Syracuse

20057

Georgetown University, Washington D.C.

21215

Sinai Hospital of Baltimore, Baltimore

21237

Franklin Square Hospital Center, Baltimore

22205

Virginia Hospital Center, Arlington

33458

Jupiter Medical Center & CyberKnife Center of Palm Beach, Jupiter

34982

Coastal CyberKnife and Radiation Oncology, Ft. Pierce

40503

Central Baptist Hospital, Lexington

48106

St. Joseph Mercy Hospital, Ann Arbor

54911

ThedaCare Appleton Medical Center, Appleton

60005

Northwest Community Hospital, Arlington Heights

61761

Community Cancer Center, Normal

63367

Lake Saint Louis Oncology, St Louis

Saint Louis University, St Louis

85013

St. Joseph's Hospital and Medical Center, Phoenix

89503

St. Mary's Regional Medical Center, Reno

92037

Scripps Cancer Center - CyberKnife of Southern California at Vista, La Jolla

92660

The CyberKnife at Newport Diagnostic Center, Newport Beach

98122

Swedish Cancer Center, Seattle

98664

Southwest Washington Medical Center, Vancouver

Southwest Washington Regional Cancer Center, Vancouver

02215

Beth Israel Deaconess Medical Center, Boston

08618

Capital Health, Trenton

All Listed Sponsors
lead

Accuray Incorporated

INDUSTRY

NCT00643994 - CyberKnife Radiosurgery for Organ-Confined Prostate Cancer: Homogenous Dose Distribution | Biotech Hunter | Biotech Hunter